Search results for "Anti-Bacterial Agents"

showing 10 items of 661 documents

Antimicrobial therapy in neonatal intensive care unit

2015

Severe infections represent the main cause of neonatal mortality accounting for more than one million neonatal deaths worldwide every year. Antibiotics are the most commonly prescribed medications in neonatal intensive care units (NICUs) and in industrialized countries about 1% of neonates are exposed to antibiotic therapy. Sepsis has often nonspecific signs and symptoms and empiric antimicrobial therapy is promptly initiated in high risk of sepsis or symptomatic infants. However continued use of empiric broad-spectrum antibiotic treatment in the setting of negative cultures especially in preterm infants may not be harmless. The benefits of antibiotic therapy when indicated are clearly enor…

medicine.medical_specialtyNeonatal intensive care unitmedicine.drug_classAntibioticsReviewGlobal HealthInfant Newborn DiseasesSepsisIntensive Care Units NeonatalIntensive caremedicineHumansAntibiotic prophylaxisAdverse effectIntensive care medicineEmpiric therapyAntibiotic stewardshipNeonatal sepsisbusiness.industryInfant NewbornAntibioticAntibiotic ProphylaxisNewbornmedicine.diseaseAnti-Bacterial AgentsAntibiotic; Antibiotic stewardship; Empiric therapy; Neonatal sepsis; Newborn; Resistant bacteria; Pediatrics Perinatology and Child HealthPediatrics Perinatology and Child HealthNeonatal sepsisNeonatal sepsiResistant bacteriabusinessEmpiric therapyItalian Journal of Pediatrics
researchProduct

Comparing medical treatments for Crohn’s disease

2013

The drugs available for inflammatory bowel disease are aminosalicylates, antibiotics, steroids, immunosuppressors and biologics. The effectiveness of these drugs has been evaluated in many randomized clinical trials, mainly versus placebo. Few studies have been conducted comparing the different drugs among themselves, owing to the methodological problems raised by comparative trials, such as sample size and blindness. This review focuses mainly on the randomized clinical trials that have compared different treatments. Of course comparisons are mainly between drugs used in a particular setting (mild, moderate and severe disease). However, on many occasions there is no homogeneity in these cl…

medicine.medical_specialtyPathologymedicine.drug_classAntibioticsAlternative medicineSevere diseasePlaceboInflammatory bowel diseaselaw.inventionBiological FactorsCrohn DiseaseRandomized controlled trialAdrenal Cortex HormoneslawInternal medicineAzathioprineIntestinal FistulaSecondary PreventionmedicineHumansBudesonideRandomized Controlled Trials as TopicCrohn's diseasebusiness.industryProbioticsHealth Policymedicine.diseaseAnti-Bacterial AgentsAminosalicylic AcidsMethotrexateSample size determinationbusinessJournal of Comparative Effectiveness Research
researchProduct

Modern Strategies in the Prevention of Implant-Associated Infections

2005

The application of medical devices either for temporary or permanent use has become an indispensible part of almost all fields of medicine. However, foreign bodies are associated with a substantial risk of bacterial and fungal infections. Implant-associated infections significantly contribute to the still increasing problem of nosocomial infections. To reduce the incidence of such infections, specific guidelines providing evidence-based recommendations and comprising both technological and nontechnological strategies for prevention have been established. Strict adherence to hygienic rules during insertion or implantation of the device are aspects of particular importance. Besides such basi…

medicine.medical_specialtyProsthesis-Related InfectionsFuture studiesmedicine.drug_class0206 medical engineeringAntibioticsBiomedical EngineeringMedicine (miscellaneous)New materialsBioengineering02 engineering and technologyBiologyProsthesis DesignBacterial AdhesionBiomaterialsCoated Materials BiocompatiblemedicineHumansConnective Tissue ProteinsIntensive care medicineForeign BodiesInfection ControlGeneral Medicine021001 nanoscience & nanotechnologyAntimicrobial020601 biomedical engineeringAnti-Bacterial AgentsSurgeryPractice Guidelines as TopicEquipment Contamination0210 nano-technologyThe International Journal of Artificial Organs
researchProduct

Medicated hydrogels of hyaluronic acid derivatives for use in orthopedic field.

2013

Physical hydrogels have been obtained from hyaluronic acid derivatized with polylactic acid in the presence or in the absence of polyethylene glycol chains. They have been extemporarily loaded with antibacterial agents, such as vancomycin and tobramycin. These medicated hydrogels have been used to coat titanium disks (chosen as simple model of orthopedic prosthesis) and in vitro studies in simulated physiological fluid have been performed as a function of time and for different drug loading and polymer concentration values. Sterilization process performed on the hydrogels does not change their rheological behavior and release properties as well as the chemical structure of starting copolyme…

medicine.medical_specialtyProsthesis-Related InfectionsPolymersPolyestersPharmaceutical SciencePolyethylene glycolengineering.materialProsthesis Designcomplex mixturesPolyethylene Glycolschemistry.chemical_compoundCoatingPolylactic acidVancomycinHyaluronic acidmedicineHumansOrthopedic ProceduresFemurLactic AcidHyaluronic AcidCells CulturedSkinchemistry.chemical_classificationTitaniumChemistrytechnology industry and agricultureSterilizationHydrogelsPolymerFibroblastsSurgeryAnti-Bacterial AgentsPolyesterSelf-healing hydrogelsengineeringTobramycinImplantRheologyBiomedical engineeringInternational journal of pharmaceutics
researchProduct

Antibiotic resistance among Shigella serogroups isolated in Tehran, Iran (2002-2004)

2009

Shigellosis, one of the most common bacterial diarrhoeal diseases, is endemic throughout the world. It is one of the major causes of morbidity in children with diarrhoea in Iran [1-4]. Antibiotic therapy is useful and effective for shigellosis. Treatment is critical for persons with severe disease, particularly children and immunosuppressed patients. Use of an appropriate antibiotic therapy can shorten the duration of symptoms, significantly reduce the risk of transmission, and also prevent potentially lethal complications [5-7]. However, high frequencies of resistance in

medicine.medical_specialtyShigellosisSevere diseaseIranSettore MED/42 - Igiene Generale E Applicatamedicine.disease_causeMicrobiologyMicrobiologyAntibiotic resistanceVirologyAntibiotic therapyInternal medicineDrug Resistance BacterialmedicineHumansShigellaChildDysentery BacillaryShigella Antibiotic resistance IranTransmission (medicine)Diarrhoeal diseasebusiness.industryGeneral Medicinemedicine.diseaseAnti-Bacterial AgentsInfectious DiseasesChild PreschoolParasitologyShigellabusinessThe Journal of Infection in Developing Countries
researchProduct

Effects of Refrigeration on the Bactericidal Activity of Human Milk: A Preliminary Study

2007

This study analyzed the bactericidal activity of human milk and how it is influenced by refrigerated storage. Nine samples of mature human milk were collected and divided into 3 aliquots. One was analyzed immediately, and the other 2 were refrigerated at 4 degrees C to 6 degrees C for 48 and 72 hours, respectively. All of the fresh samples exhibited bactericidal activity with an average value of 83.47% +/- 18.37%. Refrigeration for 48 hours did not cause significant modifications, whereas storage beyond 72 hours significantly lowered the degree of bacteriolysis versus fresh milk. In conclusion, human milk possesses bactericidal activity that remains stable during the first 48 hours of refri…

medicine.medical_specialtyTime FactorsMilk HumanFood Handlingbusiness.industryPostpartum PeriodGastroenterologyRefrigerationBreast milkBactericidal effectAnti-Bacterial AgentsFresh milkEndocrinologyRefrigerationInternal medicinePediatrics Perinatology and Child HealthEscherichia coliHumansMedicineFood sciencebusinessJournal of Pediatric Gastroenterology & Nutrition
researchProduct

Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-i…

2022

Summary Background Vancomycin is the most widely used antibiotic for neonatal Gram-positive sepsis, but clinical outcome data of dosing strategies are scarce. The NeoVanc programme comprised extensive preclinical studies to inform a randomised controlled trial to assess optimised vancomycin dosing. We compared the efficacy of an optimised regimen to a standard regimen in infants with late onset sepsis that was known or suspected to be caused by Gram-positive microorganisms. Methods NeoVanc was an open-label, multicentre, phase 2b, parallel-group, randomised, non-inferiority trial comparing the efficacy and toxicity of an optimised regimen of vancomycin to a standard regimen in infants aged …

medicine.medical_specialtyTime FactorsPopulationEquivalence Trials as TopicLoading doseArticlelaw.inventionGram-positiveRandomized controlled triallawVancomycinIntensive careInternal medicineIntensive Care Units NeonatalSepsisDevelopmental and Educational PsychologyClinical endpointMedicineHumansDosingeducationInfusions Intravenouseducation.field_of_studybusiness.industryInfant NewbornInfantdosingUnited KingdomAnti-Bacterial AgentsEuropeRegimenTreatment OutcomeSpainRelative riskPediatrics Perinatology and Child Healthsepsibusiness
researchProduct

S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2.

2019

The present guidelines are aimed at residents and board-certified physicians in the fields of dermatology, pediatrics, pediatric dermatology and pediatric rheumatology as well as policymakers and insurance funds. They were developed by dermatologists and pediatric dermatologists in collaboration with pediatric rheumatologists using a formal consensus process (S2k). The guidelines highlight topics such as disease severity, quality of life, treatment goals as well as problems associated with off-label drug therapy in children. Trigger factors and diagnostic aspects are discussed. The primary focus is on the various topical, systemic and UV-based treatment options available and includes recomm…

medicine.medical_specialtyTuberculosisAdolescentMEDLINEDermatologyDiseaseDrug Administration Schedule030207 dermatology & venereal diseases03 medical and health sciencesPsoriatic arthritisBiological Factors0302 clinical medicinePharmacotherapyQuality of life (healthcare)PsoriasismedicineHumansPsoriasisChildBiosimilar PharmaceuticalsTonsillectomybusiness.industryVaccinationmedicine.diseaseSkin CareAnti-Bacterial AgentsFamily medicineUltraviolet TherapyDermatologic AgentsbusinessGuttate psoriasisImmunosuppressive AgentsJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDGReferences
researchProduct

Daptomycin-induced eosinophilic pneumonia: Are there any risk factors?

2020

Abstract Objectives Daptomycin is a widely used antibiotic. Rhabdomyolysis related to daptomycin is one of the adverse effects of treatment, justifying the need for regular monitoring of muscle enzymes throughout treatment. Daptomycin may also lead to eosinophilic pneumonia. However, risk factors for this adverse reaction have not been identified and do not permit targeting of at-risk populations who could benefit from appropriate monitoring. Patients and methods Literature was reviewed for cases of daptomycin-induced eosinophilic pneumonia (DIEP), which that were compared to cases of patients without this adverse effect. Results Fifty patients with DIEP and 54 controls were identified. Age…

medicine.medical_specialtybusiness.industryDiseasemedicine.diseaseAnti-Bacterial AgentsInfectious DiseasesDaptomycinRisk FactorsInternal medicineDiabetes mellitusmedicineEosinophilic pneumoniaHumansDaptomycinRisk factorPulmonary EosinophiliaAdverse effectbusinessRhabdomyolysisPulmonary EosinophiliaLungmedicine.drugInfectious diseases now
researchProduct

A conservative treatment for chronic obstructive sialoadenitis by intraductal instillation of mucolytic, steroids and antibiotic solution

2021

Abstract Purposes Reporting our experience in treating chronic obstructive sialadenitis with a protocol consisting of sialoendoscopy and intraductal instillation of antibiotics, steroids and n-acetyl-cysteine (NAC) solution. Methods Prospective study of patients with chronic obstructive sialadenitis with no apparent lithiasic obstructions, with recurrent non-lithiasic sialoadenitis and patients with lithiasic sialoadenitis not solved with sialoendoscopy. In all cases, a sialoendoscopy was performed. All the patients affected by lithiasic sialoadenitis where the chronic inflammation was resolved with sialoendoscopy were excluded from the study. The mid-term follow-up was performed at 12 mont…

medicine.medical_specialtymedicine.drug_classAntibioticsConservative TreatmentIntraductal instillationSialadenitisChronic obstructive sialadenitismedicineHumansProspective StudiesSialoendoscopyProspective cohort studyExpectorantsbusiness.industryEndoscopyGeneral Medicinemedicine.diseaseSialadenitisSurgeryMiscellaneousAnti-Bacterial AgentsConservative treatmentOtorhinolaryngologyOtorhinolaryngologySialoendoscopyBetamethasoneSteroidsNeurosurgerybusinessmedicine.drug
researchProduct